• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    More On TKPYY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Takeda Pharmaceutical Company Limited (TKPYY)

    -Other OTC
    24.51 Down 0.11(0.45%) Aug 28, 4:09PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Takeda Pharmaceutical Company Limited
    1-1, Doshomachi 4-chome
    Chuo-ku
    Osaka, 540-8645
    Japan - Map
    Phone: 81 6 6204 2111
    Fax: 81 6 6204 2880
    Website: http://www.takeda.co.jp

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:31,328

    Business Summary 

    Takeda Pharmaceutical Company Limited engages in the research and development, manufacture, marketing, and sale of pharmaceutical products worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, central nervous system, immunology and respiratory, general medicine, oncology, gastroenterology, and vaccines. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Takeda Pharmaceutical Company Limited

    Key Executives 
     PayExercised
    Mr. Christophe Weber , 49
    Chief Exec. Officer, Pres and Representative Director
    2.68MN/A
    Mr. Shinji Honda , 50
    Sr. Managing Director, Sr. VP, Corp. Strategy Officer and Director
    707.00KN/A
    Mr. Iwaaki Taniguchi ,
    Sr. VP of Corp. Fin. & Controlling Department
    N/AN/A
    Mr. Andrew S. Plump M.D., Ph.D.,
    Chief Medical & Scientific Officer and Director
    N/AN/A
    Yoshihiro Nakagawa ,
    Global Gen. Counsel
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.